The Engine has reinvested in Lilac Solutions, a lithium extraction technology developer building on research at Northwestern University.

Stanford spinout DeepVision will use the cash to fund work on its edge computing hardware and software.

Congruent Ventures is among the backers of a $33m series B round for Omnidian, having already taken part in a series A round two years ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.

The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.

Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.